US FDA

The American Medical Association has laid out recommendations for how the US Food and Drug Administration should regulate generative artificial intelligence tools used in medicine. The proposal addresses oversight of AI systems that assist with clinical decisions, documentation, and patient care. Discussion centers on how regulators can ensure safety and effectiveness without stifling innovation in a fast-moving field.